Share this post on:

Product Name :
Swainsonine hydrochloride

Search keywords :
Swainsonine

drugId :
null

Target Vo:
Alpha-mannosidase 2A1

Target Vo Short Name :
MAN2A1

Moa_Name:
Alpha-mannosidase 2A1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Orexo Ab (Pulb)

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOX11 Rabbit mAb Purity & Documentation
CDC37 Antibody medchemexpress
FGFR1 Oncogene Partner Antibody: FGFR1 Oncogene Partner Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to FGFR1 Oncogene Partner. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Betaine hydrochloride